ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
AzurRx BioPharma Inc

AzurRx BioPharma Inc (AZRX)

3.45
0.00
(0.00%)
Cerrado 02 Febrero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
3.45
Postura de Compra
3.41
Postura de Venta
3.51
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
3.45
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
13,500,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.48
Beneficio por acción (BPA)
-1.19
turnover
-
Beneficio neto
-16.1M

Acerca de AzurRx BioPharma Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Dover, Delaware, USA
Fundado
-

AZRX Últimas noticias

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and Crohn’s disease, added to...

AzurRx BioPharma Announces Reverse Stock Split

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the...

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to Evaluate Efficacy of FW-1022...

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AZRX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de AzurRx BioPharma?
El precio actual de las acciones de AzurRx BioPharma es US$ 3.45
¿Cuántas acciones de AzurRx BioPharma están en circulación?
AzurRx BioPharma tiene 13,500,000 acciones en circulación
¿Cuál es la capitalización de mercado de AzurRx BioPharma?
La capitalización de mercado de AzurRx BioPharma es USD 46.58M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de AzurRx BioPharma?
AzurRx BioPharma ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de AzurRx BioPharma?
El ratio precio/beneficio de AzurRx BioPharma es -2.48
¿Cuál es la moneda de reporte de AzurRx BioPharma?
AzurRx BioPharma presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de AzurRx BioPharma?
El último beneficio anual de AzurRx BioPharma es USD -16.1M
¿Cuál es la dirección registrada de AzurRx BioPharma?
La dirección registrada de AzurRx BioPharma es 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
¿Cuál es la dirección del sitio web de AzurRx BioPharma?
La dirección del sitio web de AzurRx BioPharma es www.enterothera.com
¿En qué sector industrial opera AzurRx BioPharma?
AzurRx BioPharma opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.8M
Implanting Implanting 2 minutos hace
Interesting article on physical gold on the move. It's not just from the tariff scare.

https://www.zerohedge.com/news/2025-02-01/zh-reshoring-us-gold-has-nothing-do-trump-tariffs
FFMGF
Susie924 Susie924 2 minutos hace
Trump and Musk are feeding outrage to the media and the media is eating it up and asking for more.

I wonder what they are doing in the background while the media is in a frenzy.
Aquahoya Aquahoya 3 minutos hace
I was wrong. Clear as day. 
GSTC
al44 al44 5 minutos hace
From the Back Forty: Another Groundhog Day for Trump

We’ve been through this before, right?

by Sarah Cowgill | Feb 2, 2025

“The secret Republican plot to make liberals look like idiots, known as ‘Operation Just Let Them Speak,’ is clearly working.”
RickNagra RickNagra 7 minutos hace
Oh wow.  Big week on deck.  Press release and new updates in the works.  Exciting times ahead for all of us students and teachers and staff and shareholders in this space.  Educational component is well represented in this area.  After all only smart well educated people are buying great stocks such
GNCP
DiscoverGold DiscoverGold 8 minutos hace
Gold CoT: Peek Into Future Through Futures, How Hedge Funds Are Positioned
By: Hedgopia | February 1, 2025

• Following futures positions of non-commercials are as of January 28, 2025.

Gold: Currently net long 299.4k, down 1.4k.

hedgopia.com/wp
GDX
DiscoverGold DiscoverGold 9 minutos hace
NY Gold Futures »» Weekly Summary Analysis
By: Marty Armstrong | February 1, 2025

NY Gold Futures closed today at 28350 and is trading up about 7.34% for the year from last year's settlement of 26410. Up to this moment in time, this market has been rising for this month go
GDX
CatfishHunter CatfishHunter 9 minutos hace
Funny.  One thing MK doesn't do is release inside information. Most news of late has cause share price to trade down.  But keep stirring the pot if it makes you feel better.  
RDGL
gawti88 gawti88 10 minutos hace
45k base salary - Talk trash on boards.


haha how do you live with yourself.
CEOS
Margin Buu Margin Buu 10 minutos hace
It's funny because he doesn't deny it in his reply.
NWBO
ImjinBridger ImjinBridger 10 minutos hace
Jesus Christ
Are you addressing me??? I've had a lot of different monikers over the years, but never that. Trust me. It doesn't apply.
KBLB
DiscoverGold DiscoverGold 10 minutos hace
Gold & the Dow
By: Martin Armstrong | February 2, 2025

standard.socratesplatform.com/Blog/GetImage/679ed6a1c54f06123be89e33

While gold performed as expected, with Thursday being either the intraday high or the highest close, which is what happened, the nex
GOLD
arizona1 arizona1 10 minutos hace
I thought he was going to get rid of the Dept of Education.

https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:ur46cint3yxztzj42q4aqxjn/bafkreid2eedspciwjsevaws5yxwxmhnt75mpirw3pdam6vluxxhpwlekba@jpeg
Jetmek_03052 Jetmek_03052 11 minutos hace
Who really knows? It might actually all be true. But I'm not willing to deep six every other company that has spent billions on AI, because one Chinese company SAYS it has done the same thing for millions. It's not been proven. I also do not trust China. Its government is not to be trusted. I
NVDA
DiscoverGold DiscoverGold 11 minutos hace
Gold & the Dow
By: Martin Armstrong | February 2, 2025

standard.socratesplatform.com/Blog/GetImage/679ed6a1c54f06123be89e33

While gold performed as expected, with Thursday being either the intraday high or the highest close, which is what happened, the nex
LTListener LTListener 11 minutos hace
Good information. Highlights the value imbedded in the neuormodulator platform. It is interesting the amount of publication effort that continues to come forth. I am curious if whatever updates we end up getting as to if they have a plan to get CX-717 into clinicals for ADHD, which would be a ve
RSPI
ToddM ToddM 11 minutos hace
Chris you still alive? 
FLES
moola26 moola26 13 minutos hace
Bwahahahahaha. Yikes … McCoy totally ignored Biowin’s post! This is why we still hold

MAJORITY HOLDING STRONG$$$
Researchfyi Researchfyi 13 minutos hace
Absolutely, when you look at the bigger picture right now and compare the little successes and the growing of revenues within this part of the metals industry. LQMT is just the nat on the elephants ass.

However, if they can morph into the size of a mosquito right now, it would be enou
LQMT
AZCowboy AZCowboy 14 minutos hace
~ ADDED, & Finally ... the Original wamuq's, WMI's common shares OWNED The Washington Mutual Inc. "Holding Company" ... Period ~

as well as ... ALL That the Washington Mutual Inc. "Holding Company" ... received for its own financial participations, ... All described in one's Release'
COOP
barnyarddog barnyarddog 14 minutos hace
Now that's Entertainment !
FUBO
XMaster2023 XMaster2023 14 minutos hace
Who is kidding who? The Judge has been trying to get NWBO to settle for MONTHS. LP wants a JURY. It’s evident the Market Makers have caused severe harm to NWBO. The JURY WILL NOT BE GENTLE WITH THE MARKET MAKERS! WE ARE TALKING BILLIONS NOW TO SETTLE. Upon Approval, the settlement amount and or
NWBO
tedgoeseast tedgoeseast 15 minutos hace
Quit repeating your self I am getting tired of the same stupid post
cowtown jay cowtown jay 15 minutos hace
"USAID website goes offline in Trump administration’s 2-week-old freeze on foreign aid worldwide

USAID’s website has dropped offline without explanation in the Trump administration’s two-week-old funding freeze of U.S. foreign aid and development funding."

https://www.b

Su Consulta Reciente

Delayed Upgrade Clock